Biosimilars to shake up US drug market in 2023 and beyond despite 'problem of complexity' - Healio

8/8/2022 12:00:00 AM2 years 9 months ago

ORLANDO, Fla. — Despite the glacial pace of biosimilar uptake in the United States so far, their use is expected to cut drug costs by $54 billion over the next decade, noted a presenter at the 2022 Rheumatology Nurses Society Conference.“We think …

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.Back to Healio ORLANDO — Despite the glacial pace of bi… [+3883 chars]

full article...

Biosimilars to shake up US drug market in 2023 and beyond despite 'problem of complexity' - Healio

ORLANDO, Fla. &mdash; Despite the glacial pace of biosimilar uptake in the United States so far, their use is expected to cut drug costs by $54 billion over the next decade, noted a presenter at the 2022 Rheumatology Nurses Society Conference.&ldquo;We think …

ORLANDO, Fla. — Despite the glacial pace of biosimilar uptake in the United States so far, their use is expected to cut drug costs by $54 billion over the next decade, noted a presenter at the 2022 Rheumatology Nurses Society Conference.“We think …